XBI
State Street SPDR S&P Biotech ETF (XBI) Risk
State Street SPDR S&P Biotech ETF (XBI) ETF risk, volatility, drawdown, concentration, liquidity and risk indicators on BTI.
- Risk level
- High
- Fund category
- Sector ETF
- Largest holding weight
- 1.51%
- Daily volume
- 12,227,932.49
- Assets under management
- $7.87B
- Expense ratio
- 0.35%
State Street SPDR S&P Biotech ETF (XBI) Risk research
State Street SPDR S&P Biotech ETF (XBI) risk depends on its underlying holdings, concentration, liquidity, index design and sensitivity to market conditions. BTI currently classifies the available fund risk level as High.
Use volatility, drawdown and risk-adjusted return together rather than relying on one indicator. Also consider concentration, rate, currency and liquidity risks that may not be captured by historical price statistics.